169 related articles for article (PubMed ID: 12597310)
1. Risk factors for gallstone disease in a hospital-based study.
Lai SW; Ng KC
South Med J; 2002 Dec; 95(12):1419-23. PubMed ID: 12597310
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of fatty liver in a hospital-based study in Taiwan.
Lai SW; Tan CK; Ng KC
South Med J; 2002 Nov; 95(11):1288-92. PubMed ID: 12539995
[TBL] [Abstract][Full Text] [Related]
3. [An echographic study of the prevalence of gallstone disease in Maastricht and the surrounding area].
Thijs CT; van Engelshoven JM; Knipschild PG
Ned Tijdschr Geneeskd; 1989 Jan; 133(3):110-4. PubMed ID: 2646545
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with gallstone disease in the MICOL experience. Multicenter Italian Study on Epidemiology of Cholelithiasis.
Attili AF; Capocaccia R; Carulli N; Festi D; Roda E; Barbara L; Capocaccia L; Menotti A; Okolicsanyi L; Ricci G; Lalloni L; Mariotti S; Sama C; Scafato E
Hepatology; 1997 Oct; 26(4):809-18. PubMed ID: 9328297
[TBL] [Abstract][Full Text] [Related]
5. The risk factors for gallstone disease among senior citizens: an Oriental study.
Chen CY; Lu CL; Lee PC; Wang SS; Chang FY; Lee SD
Hepatogastroenterology; 1999; 46(27):1607-12. PubMed ID: 10430304
[TBL] [Abstract][Full Text] [Related]
6. The epidemiology of gallstone disease in Rome, Italy. Part II. Factors associated with the disease. The Rome Group for Epidemiology and Prevention of Cholelithiasis (GREPCO).
Hepatology; 1988; 8(4):907-13. PubMed ID: 3391520
[TBL] [Abstract][Full Text] [Related]
7. Independent risk factors for gallstone formation in a region with high cholelithiasis prevalence.
Völzke H; Baumeister SE; Alte D; Hoffmann W; Schwahn C; Simon P; John U; Lerch MM
Digestion; 2005; 71(2):97-105. PubMed ID: 15775677
[TBL] [Abstract][Full Text] [Related]
8. Factors influencing the prevalence of gallstones in liver disease: the beneficial and harmful influences of alcohol.
Buchner AM; Sonnenberg A
Am J Gastroenterol; 2002 Apr; 97(4):905-9. PubMed ID: 12003426
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus infection facilitates gallstone formation.
Chang TS; Lo SK; Shyr HY; Fang JT; Lee WC; Tai DI; Sheen IS; Lin DY; Chu CM; Liaw YF
J Gastroenterol Hepatol; 2005 Sep; 20(9):1416-21. PubMed ID: 16105130
[TBL] [Abstract][Full Text] [Related]
10. Gallstone disease and related risk factors in a large cohort of diabetic patients.
Pagliarulo M; Fornari F; Fraquelli M; Zoli M; Giangregorio F; Grigolon A; Peracchi M; Conte D
Dig Liver Dis; 2004 Feb; 36(2):130-4. PubMed ID: 15002821
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and risk factors of hypercholesterolemia among Thai men and women receiving health examinations.
Le D; Garcia A; Lohsoonthorn V; Williams MA
Southeast Asian J Trop Med Public Health; 2006 Sep; 37(5):1005-14. PubMed ID: 17333747
[TBL] [Abstract][Full Text] [Related]
12. Association of bowel movement frequency and use of laxatives with the occurrence of symptomatic gallstone disease in a prospective study of women.
Dukas L; Leitzmann MF; Willett WC; Colditz GA; Giovannucci EL
Am J Gastroenterol; 2001 Mar; 96(3):715-21. PubMed ID: 11280540
[TBL] [Abstract][Full Text] [Related]
13. Ten-year incidence and natural history of gallstone disease in a rural population of women in central Italy. The Rome Group for the Epidemiology and Prevention of Cholelithiasis (GREPCO).
Angelico F; Del Ben M; Barbato A; Conti R; Urbinati G
Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):249-54. PubMed ID: 9646217
[TBL] [Abstract][Full Text] [Related]
14. [A cross-sectional study of hyperuricemia in state-employees in Beijing: prevalence and risk factors].
Fang WG; Huang XM; Wang Y; Zhu WG; Bie ZX; Chen JL; Zeng XJ
Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(25):1764-8. PubMed ID: 17054844
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of gallstone disease in an Italian adult female population. Rome Group for the Epidemiology and Prevention of Cholelithiasis (GREPCO).
Am J Epidemiol; 1984 May; 119(5):796-805. PubMed ID: 6720676
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular events associated with the use of four nonselective NSAIDs (etodolac, nabumetone, ibuprofen, or naproxen) versus a cyclooxygenase-2 inhibitor (celecoxib): a population-based analysis in Taiwanese adults.
Huang WF; Hsiao FY; Wen YW; Tsai YW
Clin Ther; 2006 Nov; 28(11):1827-36. PubMed ID: 17213003
[TBL] [Abstract][Full Text] [Related]
17. The epidemiology of gallstone disease in Rome, Italy. Part I. Prevalence data in men. The Rome Group for Epidemiology and Prevention of Cholelithiasis (GREPCO).
Hepatology; 1988; 8(4):904-6. PubMed ID: 3391519
[TBL] [Abstract][Full Text] [Related]
18. Lifestyle risk factors for intrahepatic stone: findings from a case-control study in an endemic area, Taiwan.
Momiyama M; Wakai K; Oda K; Kamiya J; Ohno Y; Hamaguchi M; Nakanuma Y; Hsieh LL; Yeh TS; Chen TC; Jan YY; Chen MF; Nimura Y
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1075-81. PubMed ID: 18086119
[TBL] [Abstract][Full Text] [Related]
19. Body weight gain as the major risk factor of cholelithiasis in women and an important risk factor in man.
Ostrowska L; Czapska D; Karczewski JK
Rocz Akad Med Bialymst; 2005; 50 Suppl 1():54-6. PubMed ID: 16119627
[TBL] [Abstract][Full Text] [Related]
20. Cholelithiasis, cholecystectomy, and cancer: a case-control study in Sweden.
Lowenfels AB; Domellöf L; Lindström CG; Bergman F; Monk MA; Sternby NH
Gastroenterology; 1982 Sep; 83(3):672-6. PubMed ID: 7095370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
